For most cancers sufferers, medicines administered in medical trials might help save or lengthen lives. However regardless of 1000’s of trials in the USA annually, solely 3% to five% of eligible sufferers enroll in investigations of latest therapies. Triomics, a generative AI startup, claims it may considerably scale back the time it takes medical doctors to match […]
© 2024 TechCrunch. All rights reserved. For private use solely.